Next Level
Gene Silencing
copyright microsoft
Would you like to stay updated on news from PRAMO?
PRAMOMOLECULAR is developing "self-delivering siRNAs", based on our platform technology, a highly innovative class of drugs that can efficiently down-regulate disease-causing proteins such as mutated or over-expressed proteins
Our team
Merle Fuchs, PhD
CEO & Co-Founder Tel: +49 171 45 42 042
fuchs@pramomolecular.com
Ida Shaef, M.Sc
CSO & Co-Founder Tel: +49 30 94893350
shaef@pramomolecular.com
Thomas Hiller, PhD
CTO & Co-Founder Tel: +49 30 94893350
hiller@pramomolecular.com
Thomas Eichinger, PhD
Head CMC
Contact
Contact Us
PRAMOMOLECULAR GmbH
Robert-Rössle-Strasse 10
13125 Berlin
Building D79 / 1st Floor
+49 30 94893350
Investment Information Sheet (IIS) in accordance with Sections 2a and 13 of the German Investment Products Act (VermAnlG) of PRAMOMOLECULAR GmbH
This document is an English translation of the original German version of the Vermögensanlagen-Informationsblatt (VIB). It is provided for informational purposes only and has no legal or official meaning. In case of any discrepancies or legal relevance, only the German version shall be binding.
